ABSTRACT
Introduction Gynaecological cancers represent 12-15% of all cancers affecting women (Jelfs et al. 1994). The majority are diagnosed in older women, but 21% are in women of reproductive age (Jelfs et al. 1994). With improved treatment, most gynaecological cancers have good survival rates. Quality-of-life issues-including preservation of fertility-- are therefore of increasing importance. Many women of reproductive age who have survived gynaecological cancer wish to have children. However, even with the advances in reproductive technologies, the options for these women remain limited, with many treatments still being in the research stages.
